• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.一种跨膜丝氨酸蛋白酶与严重急性呼吸综合征冠状病毒受体相连,并激活病毒进入。
J Virol. 2011 Jan;85(2):873-82. doi: 10.1128/JVI.02062-10. Epub 2010 Nov 10.
2
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.TMPRSS2 和 ADAM17 对 ACE2 的切割具有差异性,只有 TMPRSS2 的蛋白水解作用才能增强严重急性呼吸综合征冠状病毒刺突蛋白驱动的进入。
J Virol. 2014 Jan;88(2):1293-307. doi: 10.1128/JVI.02202-13. Epub 2013 Nov 13.
3
Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction TMPRSS2 activation of membrane fusion.蝙蝠类严重急性呼吸系统综合征相关冠状病毒利用多种动物的 ACE2 作为受体,同时逃避 IFITM3 限制和 TMPRSS2 介导的膜融合激活。
Emerg Microbes Infect. 2020 Dec;9(1):1567-1579. doi: 10.1080/22221751.2020.1787797.
4
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
5
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.SARS-CoV-2 和 SARS-CoV 的刺突介导的细胞融合在受体表达和蛋白水解激活的要求上存在差异。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.00002-21.
6
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.高效激活严重急性呼吸综合征冠状病毒刺突蛋白需要跨膜蛋白酶 TMPRSS2。
J Virol. 2010 Dec;84(24):12658-64. doi: 10.1128/JVI.01542-10. Epub 2010 Oct 6.
7
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.ACE2 作为一种新型调节剂,调节 TMPRSS2 对呼吸道细胞中甲型流感病毒的蛋白水解激活作用。
J Virol. 2024 Apr 16;98(4):e0010224. doi: 10.1128/jvi.00102-24. Epub 2024 Mar 12.
8
Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats.蝙蝠中与严重急性呼吸系统综合症冠状病毒相关的利用 ACE2 的冠状病毒证据。
J Virol. 2012 Jun;86(11):6350-3. doi: 10.1128/JVI.00311-12. Epub 2012 Mar 21.
9
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.严重急性呼吸综合征冠状病毒刺突蛋白的裂解和激活由人呼吸道胰蛋白酶样蛋白酶。
J Virol. 2011 Dec;85(24):13363-72. doi: 10.1128/JVI.05300-11. Epub 2011 Oct 12.
10
Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin.严重急性呼吸综合征(SARS)冠状病毒与源自蝙蝠的类SARS冠状病毒在受体使用上的差异。
J Virol. 2008 Feb;82(4):1899-907. doi: 10.1128/JVI.01085-07. Epub 2007 Dec 12.

引用本文的文献

1
Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy.基于类器官的中和试验揭示了SARS-CoV-2抗体的独特特征,并概括了实际疗效。
Proc Natl Acad Sci U S A. 2025 Sep 2;122(35):e2509616122. doi: 10.1073/pnas.2509616122. Epub 2025 Aug 28.
2
FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.经美国食品药品监督管理局批准的药物作为新型冠状病毒关键蛋白的潜在共价抑制剂:一种计算机模拟方法。
Turk J Biol. 2025 Apr 7;49(3):233-246. doi: 10.55730/1300-0152.2741. eCollection 2025.
3
ACE-2 blockade and TMPRSS2 inhibition mitigate SARS-CoV-2 severity following cigarette smoke exposure in airway epithelial cells .在气道上皮细胞中,抑制血管紧张素转换酶2(ACE-2)和跨膜丝氨酸蛋白酶2(TMPRSS2)可减轻香烟烟雾暴露后新型冠状病毒肺炎(SARS-CoV-2)的严重程度。
Mol Ther Nucleic Acids. 2025 Jun 2;36(3):102580. doi: 10.1016/j.omtn.2025.102580. eCollection 2025 Sep 9.
4
Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET.通过原位冷冻电子断层扫描揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)融合的结构谱。
Nat Commun. 2025 Jun 3;16(1):5150. doi: 10.1038/s41467-025-60406-z.
5
A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity.一种新型抗病毒治疗平台:将干扰素-β锚定在感染性病毒粒子表面赋予逃避干扰素的病毒粒子强大的抗病毒活性。
Viruses. 2025 May 13;17(5):697. doi: 10.3390/v17050697.
6
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入机制的受体结合:来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
7
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.从N-0385到N-0920:揭示一种对流行的SARS-CoV-2变体具有皮摩尔抗病毒效力的宿主导向蛋白酶抑制剂。
J Med Chem. 2025 Apr 10;68(7):7119-7136. doi: 10.1021/acs.jmedchem.4c02468. Epub 2025 Mar 31.
8
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET.通过原位冷冻电子断层扫描揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)融合阶段的全貌
bioRxiv. 2025 Feb 27:2025.02.25.640151. doi: 10.1101/2025.02.25.640151.
9
Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy.脑脊液血管紧张素转换酶2片段增加作为新冠病毒脑病患者脑部感染的一项指标
J Infect Dis. 2025 Jun 2;231(5):e929-e940. doi: 10.1093/infdis/jiaf093.
10
Development of Receptor-Integrated Magnetically Labeled Liposomes for Investigating SARS-CoV-2 Fusion Interactions.用于研究 SARS-CoV-2 融合相互作用的受体整合磁性标记脂质体的开发
Anal Chem. 2025 Mar 4;97(8):4490-4498. doi: 10.1021/acs.analchem.4c05966. Epub 2025 Feb 10.

本文引用的文献

1
TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.TMPRSS2 和 TMPRSS4 促进了流感病毒在 Caco-2 细胞中的无胰蛋白酶依赖性扩散。
J Virol. 2010 Oct;84(19):10016-25. doi: 10.1128/JVI.00239-10. Epub 2010 Jul 14.
2
Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.气道蛋白酶对 SARS 冠状病毒刺突糖蛋白的切割增强了病毒在体外进入人支气管上皮细胞的能力。
PLoS One. 2009 Nov 17;4(11):e7870. doi: 10.1371/journal.pone.0007870.
3
Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme.肿瘤坏死因子α转换酶对血管紧张素转换酶2胞外域脱落的选择性和特异性调节
Am J Physiol Cell Physiol. 2009 Nov;297(5):C1318-29. doi: 10.1152/ajpcell.00036.2009. Epub 2009 Sep 16.
4
Type II transmembrane serine proteases.II型跨膜丝氨酸蛋白酶
J Biol Chem. 2009 Aug 28;284(35):23177-81. doi: 10.1074/jbc.R109.021006. Epub 2009 Jun 1.
5
Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.人呼吸道上皮细胞中血管紧张素转换酶2的胞外域脱落
Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L84-96. doi: 10.1152/ajplung.00071.2009. Epub 2009 May 1.
6
Activation of a membrane-bound serine protease matriptase on the cell surface.细胞表面膜结合丝氨酸蛋白酶matriptase的激活。
J Biochem. 2009 Aug;146(2):273-82. doi: 10.1093/jb/mvp066. Epub 2009 Apr 26.
7
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.通过在两个不同位点进行顺序蛋白水解切割来激活严重急性呼吸综合征冠状病毒刺突蛋白。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6. doi: 10.1073/pnas.0809524106. Epub 2009 Mar 24.
8
Proteolytic activation of the 1918 influenza virus hemagglutinin.1918年流感病毒血凝素的蛋白水解激活作用。
J Virol. 2009 Apr;83(7):3200-11. doi: 10.1128/JVI.02205-08. Epub 2009 Jan 21.
9
Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2.富含胆固醇的膜微区在严重急性呼吸综合征冠状病毒S蛋白与细胞受体血管紧张素转换酶2相互作用中的重要性。
Virology. 2008 Nov 25;381(2):215-21. doi: 10.1016/j.virol.2008.08.026. Epub 2008 Sep 23.
10
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2.人偏肺病毒在表达跨膜丝氨酸蛋白酶TMPRSS2的Vero细胞中的高效增殖。
J Virol. 2008 Sep;82(17):8942-6. doi: 10.1128/JVI.00676-08. Epub 2008 Jun 18.

一种跨膜丝氨酸蛋白酶与严重急性呼吸综合征冠状病毒受体相连,并激活病毒进入。

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.

机构信息

Department of Microbiology and Immunology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.

出版信息

J Virol. 2011 Jan;85(2):873-82. doi: 10.1128/JVI.02062-10. Epub 2010 Nov 10.

DOI:10.1128/JVI.02062-10
PMID:21068237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3020023/
Abstract

Spike (S) proteins, the defining projections of the enveloped coronaviruses (CoVs), mediate cell entry by connecting viruses to plasma membrane receptors and by catalyzing subsequent virus-cell membrane fusions. The latter membrane fusion requires an S protein conformational flexibility that is facilitated by proteolytic cleavages. We hypothesized that the most relevant cellular proteases in this process are those closely linked to host cell receptors. The primary receptor for the human severe acute respiratory syndrome CoV (SARS) CoV is angiotensin-converting enzyme 2 (ACE2). ACE2 immunoprecipitation captured transmembrane protease/serine subfamily member 2 (TMPRSS2), a known human airway and alveolar protease. ACE2 and TMPRSS2 colocalized on cell surfaces and enhanced the cell entry of both SARS S-pseudotyped HIV and authentic SARS-CoV. Enhanced entry correlated with TMPRSS2-mediated proteolysis of both S and ACE2. These findings indicate that a cell surface complex comprising a primary receptor and a separate endoprotease operates as a portal for activation of SARS-CoV cell entry.

摘要

刺突(S)蛋白是包膜冠状病毒(CoV)的特有突起,通过将病毒连接到质膜受体并催化随后的病毒-质膜融合来介导细胞进入。后者的膜融合需要 S 蛋白构象的灵活性,这是由蛋白水解切割促进的。我们假设在这个过程中最相关的细胞蛋白酶是那些与宿主细胞受体密切相关的蛋白酶。人类严重急性呼吸系统综合征冠状病毒(SARS-CoV)的主要受体是血管紧张素转换酶 2(ACE2)。ACE2 的免疫沉淀捕获了跨膜蛋白酶/丝氨酸亚家族成员 2(TMPRSS2),这是一种已知的人类气道和肺泡蛋白酶。ACE2 和 TMPRSS2 在细胞表面共定位,并增强了 SARS S 假型 HIV 和真正的 SARS-CoV 的细胞进入。增强的进入与 TMPRSS2 介导的 S 和 ACE2 的蛋白水解相关。这些发现表明,包含主要受体和单独的内肽酶的细胞表面复合物作为 SARS-CoV 细胞进入的激活门户起作用。